Literature DB >> 12796773

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Monica Autiero1, Johannes Waltenberger, Didier Communi, Andrea Kranz, Lieve Moons, Diether Lambrechts, Jens Kroll, Stephane Plaisance, Maria De Mol, Françoise Bono, Stefanie Kliche, Guido Fellbrich, Kurt Ballmer-Hofer, Domenico Maglione, Ulrike Mayr-Beyrle, Mieke Dewerchin, Saskia Dombrowski, Danica Stanimirovic, Paul Van Hummelen, Christoph Dehio, Daniel J Hicklin, Graziella Persico, Jean-Marc Herbert, David Communi, Masabumi Shibuya, Désiré Collen, Edward M Conway, Peter Carmeliet.   

Abstract

Therapeutic angiogenesis is likely to require the administration of factors that complement each other. Activation of the receptor tyrosine kinase (RTK) Flk1 by vascular endothelial growth factor (VEGF) is crucial, but molecular interactions of other factors with VEGF and Flk1 have been studied to a limited extent. Here we report that placental growth factor (PGF, also known as PlGF) regulates inter- and intramolecular cross talk between the VEGF RTKs Flt1 and Flk1. Activation of Flt1 by PGF resulted in intermolecular transphosphorylation of Flk1, thereby amplifying VEGF-driven angiogenesis through Flk1. Even though VEGF and PGF both bind Flt1, PGF uniquely stimulated the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Furthermore, the VEGF/PGF heterodimer activated intramolecular VEGF receptor cross talk through formation of Flk1/Flt1 heterodimers. The inter- and intramolecular VEGF receptor cross talk is likely to have therapeutic implications, as treatment with VEGF/PGF heterodimer or a combination of VEGF plus PGF increased ischemic myocardial angiogenesis in a mouse model that was refractory to VEGF alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796773     DOI: 10.1038/nm884

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  230 in total

1.  Placental growth factor mediates aldosterone-dependent vascular injury in mice.

Authors:  Iris Z Jaffe; Brenna G Newfell; Mark Aronovitz; Najwa N Mohammad; Adam P McGraw; Roger E Perreault; Peter Carmeliet; Afshin Ehsan; Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.

Authors:  Georges von Degenfeld; Andrea Banfi; Matthew L Springer; Helen M Blau
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  Substitution of C-terminus of VEGFR-2 with VEGFR-1 promotes VEGFR-1 activation and endothelial cell proliferation.

Authors:  Rosana D Meyer; Amrik Singh; Fredric Majnoun; Catharina Latz; Kameran Lashkari; Nader Rahimi
Journal:  Oncogene       Date:  2004-07-15       Impact factor: 9.867

4.  Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.

Authors:  Maurizio Mandalà; Natalia Gokina; Carolyn Barron; George Osol
Journal:  J Vasc Res       Date:  2011-10-06       Impact factor: 1.934

Review 5.  Signal transduction by vascular endothelial growth factor receptors.

Authors:  Sina Koch; Lena Claesson-Welsh
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 6.  Skin wound healing modulation by macrophages.

Authors:  Mathieu P Rodero; Kiarash Khosrotehrani
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

7.  PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.

Authors:  Laura F Newell; Shernan G Holtan; Jane E Yates; Leonardo Pereira; Jeffrey W Tyner; Irina Burd; Grover C Bagby
Journal:  Am J Reprod Immunol       Date:  2017-06-20       Impact factor: 3.886

8.  Placental growth factor signaling regulates isoform splicing of vascular endothelial growth factor A in the control of lung cancer cell metastasis.

Authors:  Zanfeng Wang; Tingwei Liu
Journal:  Mol Cell Biochem       Date:  2017-08-31       Impact factor: 3.396

Review 9.  Clinical pharmacology of intravitreal anti-VEGF drugs.

Authors:  Stefano Fogli; Marzia Del Re; Eleonora Rofi; Chiara Posarelli; Michele Figus; Romano Danesi
Journal:  Eye (Lond)       Date:  2018-02-05       Impact factor: 3.775

10.  Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Shoko Ohnuma; Nobutaka Ohgami; Hisao Naito; Hossain U Shekhar; Yasuhiro Omata; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.